Under construction – not a live service
Sign in
Not yet taking people in FranceNo phase

Exercise program study for women with obesity, with or without PCOS

Tests an adapted exercise program in women with excess weight and PCOS.

Key facts

Who runs it
University Hospital, Clermont-Ferrand
Where
Clermont-Ferrand, FranceSee the site
Trial code
Registry title
Physical Activity and Cardiometabolic Health in Women With or Without Polycystic Ovary Syndrome (SCOPAP)
Status
Not yet recruiting
People taking part
40 people, planned
Started
Jul 2026
Expected to end
Dec 2028
Type of study
Interventional
Treatments tested
  • Physical activity
Record updated
22 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18 to 40 with overweight or obesity, with or without polycystic ovary syndrome, to test an adapted physical activity program.

Age
18 to 40 years
Sex
Women only
Disease stage
Body mass index (BMI) between 25 and 40 kg/m². One group has polycystic ovary syndrome and another group does not.
Earlier treatment
Must not have had drug treatment for obesity in the past two years. Must do no more than 150 minutes of moderate-to-vigorous physical activity per week.

Main reasons for not taking part

  • Pregnant or breastfeeding
  • Postmenopausal
  • Taking or recently taking drug treatment for obesity (within two years)
  • Under legal protection measures (guardianship, curatorship or judicial protection)
  • Refusing to sign the informed consent form

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Women aged 18 to 40 years (inclusive boundaries)
  • Women with a body mass index (BMI) between 25 and 40 kg/m²
  • Women performing no more than 150 minutes of moderate-to-vigorous physical activity per week
  • Women able to provide informed consent to participate
  • Women affiliated with a social security system
  • One group will consist of women with polycystic ovary syndrome, and another group will consist of women without polycystic ovary syndrome

Who cannot take part

  • Women currently receiving pharmacological treatment for obesity or who have received such treatment within the past two years
  • Pregnancy or breastfeeding, as declared by the participant
  • Postmenopausal women
  • Women under legal protection measures (guardianship, curatorship, or judicial protection)
  • Refusal to sign the informed consent form

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

Where in France

  • CHU de Clermont-FerrandClermont-Ferrand, FranceContact: Lise LaclautreNo longer taking part

About the trial

What the trial wants to find out

The primary objective of this study is to investigate the effects of a multidisciplinary intervention, including a targeted adapted physical activity program, on lipid oxidation during a walking exercise in women with overweight or obesity, with or without polycystic ovary syndrome. Specifically, the study aims to compare changes in lipid oxidation before and after the intervention between women with polycystic ovary syndrome and those without polycystic ovary syndrome.

Read full original descriptionShow less

The secondary objectives are to assess the impact of polycystic ovary syndrome on several physiological and metabolic parameters in women with overweight or obesity. These include: (i) resting energy metabolism; (ii) resting blood pressure and heart rate; (iii) energy expenditure, energy cost, and heart rate during a walking exercise; (iv) body composition, glycemic and lipid profiles, and circulating levels of sex hormones and adipokines; (v) movement behaviors; and (vi) physical fitness.

In addition, the effect of the multidisciplinary intervention, including the adapted physical activity program, will be evaluated on these same outcomes: (i) resting energy metabolism; (ii) resting blood pressure and heart rate; (iii) energy expenditure, energy cost, and heart rate during walking exercise; (iv) body composition, glycemic and lipid profiles, and concentrations of sex hormones and adipokines; (v) movement behaviors; and (vi) physical fitness, in women with overweight or obesity, with or without polycystic ovary syndrome.

The group in the trial

  • Physical activity interventionTreatment being tested

    Treatment: Physical activity

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cardiometabolic Health in Women With Overweight or Obesity, With or Without Polycystic Ovary Syndrome: Effects of a Targeted Adapted Physical Activity Program
Plain-language title
Exercise program study for women with obesity, with or without PCOSGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07659392, who can take part
Record updated
22 June 2026